我们的目的是确定各种可用的口服，topic,以及雄激素性脱发患者脱发的程序性治疗选择。使用系统审查和荟萃分析指南的首选报告项目，对国家医学图书馆进行了系统评价.总的来说,141项独特研究符合我们的纳入标准。我们证明了许多非处方药(例如局部米诺地尔，补充剂,低水平光处理)，处方(例如口服米诺地尔，非那雄胺,dutasteride),和程序(例如富血小板血浆，分馏激光器，毛发移植)治疗成功促进毛发生长，强调多方面和个性化管理方法的优越性。
We aimed to determine the efficacy of the various available oral, topical, and procedural treatment options for hair loss in individuals with androgenic alopecia. Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, a systematic review of the National Library of Medicine was performed. Overall, 141 unique studies met our inclusion criteria. We demonstrate that many over the counter (e.g. topical minoxidil, supplements, low-level light treatment), prescription (e.g. oral minoxidil, finasteride, dutasteride), and procedural (e.g. platelet-rich plasma, fractionated lasers, hair transplantation) treatments successfully promote hair growth, highlighting the superiority of a multifaceted and individualized approach to management.
